Table 9.

Change in Other Psychometric Measures Mean Scores During Phase II: Comparison of Participants Receiving Adjunctive Psychotropic Medications with Participants Not Receiving Adjunctive Psychotropic Medications

	No adjunctive psychotropic medications n=16			Adjunctive psychotropic medications n=25			Mean difference in change scores
Instrument	Phase II baseline Mean (SD)	End of Phase II Mean (SD)	p	Phase II baseline Mean (SD)	End of Phase II Mean (SD)	p	Mean (SD)	p
ADHD Rating Scale-IV (ARS-IV)
Total score	23.9 (9.4)	21.3 (11.3)	0.14	32.0 (11.9)	32.3 (12.9)	0.99	2.6 (12.0)	0.45
Inattention	14.8 (4.9)	13.1 (5.7)	0.11	18.3 (5.9)	18.2 (6.6)	0.89	1.5 (6.3)	0.40
Hyperactivity-Impulsivity	9.1 (5.7)	8.2 (6.6)	0.36	13.7 (6.9)	14.1 (7.3)	0.89	1.0 (6.2)	0.56
Brief Psychiatric Rating Scale for Children (BPRS-C)
Total score	11.7 (7.7)	10.7 (6.9)	0.61	13.6 (7.8)	14.0 (10.3)	0.87	−1.5 (10.7)	0.67
Caregiver Strain Questionnaire (CSQ)
Total score	49.1 (19.9)	44.1 (11.0)	0.21	56.3 (18.8)	56.1 (19.9)	0.99	−4.9 (18.0)	0.41
Parent General Behavior Inventory-10 Item Mania Scale (PGBI-10M)
Total score	6.9 (6.5)	4.5 (4.4)	0.08	10.6 (6.2)	10.4 (8.6)	0.88	−2.1 (7.9)	0.37
Irritability, Depression, and Anxiety (IDA)
Total score	4.2 (2.9)	5.4 (4.1)	0.10	4.1 (3.3)	4.8 (4.3)	0.44	0.6 (3.8)	0.65
Nisonger Child Behavior Rating Form-TIQ (NCBRF-TIQ)
Conduct Problem	16.0 (6.0)	15.2 (4.5)	0.60	17.7 (4.4)	17.3 (5.0)	0.49	0.0 (5.3)	0.98
ADHD-Total	8.6 (4.7)	7.3 (3.2)	0.27	10.0 (3.4)	10.4 (4.4)	0.97	−1.3 (4.5)	0.38
Pediatric Anxiety Rating Scale (PARS)
Total score with five items	2.7 (4.5)	2.5 (4.2)	0.75	3.8 (6.5)	1.8 (4.7)	0.17	1.8 (5.9)	0.28

ADHD, attention-deficit/hyperactivity disorder.